The global real world evidence solutions market in terms of revenue was estimated to be worth $1.5 billion in 2022 and is poised to reach $2.9 billion by 2027, growing at a CAGR of 15.2% from 2022 to

The global real world evidence solutions market in terms of revenue was estimated to be worth $1.5 billion in 2022 and is poised to reach $2.9 billion by 2027, growing at a CAGR of 15.2% from 2022 to

The rising prevalence of end-stage renal disease (ESRD), diabetes, and hypertension is stimulating the demand for dialysis treatment in the emerging nations. Furthermore, low preference of patients fo...

The global interventional radiology products market is projected to reach USD 14.1 billion by 2026, at a CAGR of 6.6% during the forecast period. The growth in this market can be attributed to the ris...

The global interventional radiology products market is projected to reach USD 14.1 billion by 2026, at a CAGR of 6.6% during the forecast period. The growth in this market can be attributed to the ris...

The global osteoarthritis therapeutics market in terms of revenue was estimated to be worth $7.3 billion in 2020 and is poised to reach $11.0 million by 2025, growing at a CAGR of 8.7% from 2020 to 20...

The Growth in this market is driven by the using consistent, standardized clinical terminology to help medical practitioners access and understand clinical data found in healthcare applications, gover...

Growth in this market is driven mainly by the increasing incidence of chronic diseases, government investments for cell-based research, the growing focus on personalized medicine, increasing focus on

The competitive landscape includes the analysis of the key growth strategies adopted by major players between 2018–2020 to expand their global presence and increase their market shares in the emboloth...

The significant rise in demand for CRRT in the treatment of hemodynamically unstable patients. Moreover, the development and commercialization of novel renal replacement solutions also support market